These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10393567)

  • 61. [Difficulties encountered during formulation of a parenteral dosage form containing a poorly soluble drug].
    Kovács K; Orosz T; Stampf G; Antal I; Klebovich I; Ludányi K
    Acta Pharm Hung; 2009; 79(1):35-44. PubMed ID: 19526681
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches.
    Fakes MG; Vakkalagadda BJ; Qian F; Desikan S; Gandhi RB; Lai C; Hsieh A; Franchini MK; Toale H; Brown J
    Int J Pharm; 2009 Mar; 370(1-2):167-74. PubMed ID: 19100319
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Use of Glycerol as an Enabling Excipient for Microwave-Induced In Situ Drug Amorphization.
    Hempel NJ; Morsch F; Knopp MM; Berthelsen R; Löbmann K
    J Pharm Sci; 2021 Jan; 110(1):155-163. PubMed ID: 33058897
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug.
    Li P; Hynes SR; Haefele TF; Pudipeddi M; Royce AE; Serajuddin AT
    J Pharm Sci; 2009 May; 98(5):1750-64. PubMed ID: 18781639
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Ensuring Product Stability - Choosing the Right Excipients.
    Veronica N; Heng PWS; Liew CV
    J Pharm Sci; 2022 Aug; 111(8):2158-2171. PubMed ID: 35526577
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chemical stability of an ester prodrug of a glycoprotein IIb/IIIa receptor antagonist in solid dosage forms.
    Badawy SI; Williams RC; Gilbert DL
    J Pharm Sci; 1999 Apr; 88(4):428-33. PubMed ID: 10187753
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Physical and chemical properties of DMP 504, a polyalkylammonium-based bile acid sequestrant.
    Raghavan KS; Chang RK; Pang J; Figuly GD; Hussain MA
    Pharm Dev Technol; 1997 Aug; 2(3):233-41. PubMed ID: 9552451
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Amino acids as co-amorphous stabilizers for poorly water-soluble drugs--Part 2: molecular interactions.
    Löbmann K; Laitinen R; Strachan C; Rades T; Grohganz H
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):882-8. PubMed ID: 23567485
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stability considerations in liquid dosage forms extemporaneously prepared from commercially available products.
    Glass BD; Haywood A
    J Pharm Pharm Sci; 2006; 9(3):398-426. PubMed ID: 17207422
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir.
    Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K
    Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Glass fragility and the stability of pharmaceutical preparations--excipient selection.
    Hatley RH
    Pharm Dev Technol; 1997 Aug; 2(3):257-64. PubMed ID: 9552453
    [TBL] [Abstract][Full Text] [Related]  

  • 72. PharmDE: A new expert system for drug-excipient compatibility evaluation.
    Wang N; Sun H; Dong J; Ouyang D
    Int J Pharm; 2021 Sep; 607():120962. PubMed ID: 34339812
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Vial breakage during freeze-drying: crystallization of sodium chloride in sodium chloride-sucrose frozen aqueous solutions.
    Milton N; Gopalrathnam G; Craig GD; Mishra DS; Roy ML; Yu L
    J Pharm Sci; 2007 Jul; 96(7):1848-53. PubMed ID: 17299763
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Screening method to identify preclinical liquid and semi-solid formulations for low solubility compounds: miniaturization and automation of solvent casting and dissolution testing.
    Mansky P; Dai WG; Li S; Pollock-Dove C; Daehne K; Dong L; Eichenbaum G
    J Pharm Sci; 2007 Jun; 96(6):1548-63. PubMed ID: 17094139
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The use of isothermal heat conduction microcalorimetry to evaluate drug stability in tablets.
    Selzer T; Radau M; Kreuter J
    Int J Pharm; 1999 Jul; 184(2):199-206. PubMed ID: 10387949
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The Role of Solid State Characterization in Predicting Stability of Solid Dosage Forms.
    Szabó P; Zelko R; Antal I
    Curr Pharm Des; 2016; 22(32):5019-5028. PubMed ID: 27464730
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Decision Support for Excipient Risk Assessment in Pharmaceutical Manufacturing.
    Bejarano A; Hewa Nadungodage C; Wang F; Catlin AC; Hoag SW
    AAPS PharmSciTech; 2019 Jun; 20(6):223. PubMed ID: 31214878
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Influence of commonly used excipients on the chemical degradation of enalapril maleate in its solid state: The role of condensed water.
    Bout MR; Vromans H
    Eur J Pharm Sci; 2022 Apr; 171():106121. PubMed ID: 35007714
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Solid-state stability of aspirin in the presence of excipients: kinetic interpretation, modeling, and prediction.
    Mroso PV; Li Wan Po A; Irwin WJ
    J Pharm Sci; 1982 Oct; 71(10):1096-101. PubMed ID: 7143203
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Polymorphic and Covalent Transformations of Gabapentin in Binary Excipient Mixtures after Milling-Induced Stress.
    Tinmanee R; Stamatis SD; Ueyama E; Morris KR; Kirsch LE
    Pharm Res; 2018 Feb; 35(2):39. PubMed ID: 29392513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.